The Cigna Group
Recent
price
P/E
ratio
div
yld
2.23%
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- The Cigna Group operates as a global health services company primarily in the United States, with significant international operations across more than 30 countries. Founded in 1792 and headquartered in Bloomfield, Connecticut, Cigna delivers a comprehensive range of health insurance and related services. Its core offerings include medical, dental, behavioral health, pharmacy benefits management, specialty pharmacy services, vision, and supplemental insurance products. The company serves both insured and self-insured customers through Cigna Healthcare, which includes U.S. Commercial, U.S. Government, and International Health segments. Cigna Healthcare's product portfolio incorporates Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans. Additionally, Cigna provides integrated behavioral, medical, and pharmacy management solutions, health advocacy programs, care management, and advanced analytics through its Evernorth Health Services segment. Evernorth encompasses coordinated and point solution health services including home delivery pharmacy, specialty pharmaceutical distribution, care delivery, and benefit management for health plans, employers, government organizations, and healthcare providers. Recent major changes at Cigna include the 2023 rebranding of its holding company to The Cigna Group, with its health benefits provider business unit named Cigna Healthcare and its health services unit renamed Evernorth Health Services. In early 2024, Cigna agreed to sell its Medicare Advantage, Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC) in a transaction valued at approximately $3.7 billion, which closed in March 2025. This strategic move marks Cigna’s exit from the Medicare Advantage space to refocus on other growth areas. Leadership changes in January 2024 appointed Brian Evanko as President and CEO of Cigna Healthcare to unify and accelerate innovation and growth across the healthcare businesses. Cigna continues to emphasize reducing member healthcare costs and improving patient access by simplifying prior authorizations and expanding advocacy for complex conditions. The company also retains a strong presence in pharmacy benefits management through Express Scripts, which remains a significant profit generator. Cigna targets a broad range of customers including employers, union groups, Medicare and Medicaid beneficiaries, individuals, and multinational corporations, supported by a global footprint extending across more than 30 countries. The company’s product suite is designed to deliver integrated healthcare solutions, combining insurance coverage with care management and pharmacy services to improve health outcomes and control costs. Cigna distributes its products through brokers, consultants, direct employer relationships, and public and private exchanges. Overall, The Cigna Group is a comprehensive healthcare services provider offering multi-faceted insurance products and health management solutions, with a strategic focus on growth through innovation, customer-centric care, and operational efficiency within its core U.S. and international markets. Its recent divestiture of Medicare Advantage businesses and leadership restructuring reflect a significant strategic realignment aimed at strengthening its health services and integrated medical offerings.
Company News
Critical Review: Quest Diagnostics (NYSE:DGX) & Cigna Group (NYSE:CI)
A Look at The Cigna Group (CI) After 3.2% Gain -- GF Value $395.87 vs Price $298.81
Under the Hood: Strong Demand, Higher Real Rates, and What It Means for Portfolios
Here's Why Cigna (CI) is a Strong Value Stock
The Cigna Group's Third Quarter 2026 Earnings Release Details
3,547 Shares of Cigna Group $CI Purchased by Titleist Asset Management LLC
Here's Why Cigna (CI) is a Strong Growth Stock
Cigna Healthcare Introduces Health Sense To Connect Guidance, Benefits and Clinical Support Around Each Person, Improving Affordability and Outcomes
Cigna: Deeply Undervalued With Expected Double-Digit EPS Growth Ahead
The Cigna Group (CI) Analyst/Investor Day Transcript
Cigna Reaffirms 2026 Outlook, Targets Complex Care and AI-Driven Growth
Cigna Group (CI) Reaffirms FY26 Guidance Amid Investor Day Insights
Cigna to invest $3 billion in multi-year initiative to improve workflow
The Cigna Group Hosts 2026 Investor Day; Introduces "Lead to One" to Drive Durable Growth Through Complex Care Leadership and Differentiated Capabilities
Cigna Group (NYSE:CI) Stock Rated “Moderate Buy” by Sell-Side Analysts
Cigna Stock in Focus as Investor Day Spotlights Specialty Drugs
Why Cigna (CI) is a Top Value Stock for the Long-Term
Defying Headwinds, the U.S. Economy Continues to Flex Its Resilience
Hitachi High-Tech opens Advanced-Technology Innovation Center Mumbai, India which is predominantly focusing on analytical systems for chemical and industries including biopharmaceuticals
Can Cigna's AI Push Help Rein In Rising Healthcare Costs?